Tekla Capital Management LLC - IMMUNOMEDICS INC ownership

IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 418 filers reported holding IMMUNOMEDICS INC in Q3 2020. The put-call ratio across all filers is 0.82 and the average weighting 1.3%.

Quarter-by-quarter ownership
Tekla Capital Management LLC ownership history of IMMUNOMEDICS INC
ValueSharesWeighting
Q3 2020$18,990,000
+7.8%
223,336
-55.1%
0.71%
+6.1%
Q2 2020$17,617,000
+168.3%
497,103
+2.1%
0.67%
+125.9%
Q1 2020$6,566,000
-36.3%
487,1030.0%0.30%
-23.8%
Q4 2019$10,307,000
+59.6%
487,1030.0%0.39%
+38.3%
Q3 2019$6,459,000
+19.6%
487,103
+25.1%
0.28%
+28.2%
Q2 2019$5,400,000
-2.3%
389,313
+35.3%
0.22%
-1.8%
Q1 2019$5,526,000
-10.3%
287,687
-33.3%
0.22%
-15.2%
Q4 2018$6,158,000
+203.6%
431,527
+343.2%
0.26%
+256.8%
Q3 2018$2,028,000
+5.9%
97,370
-80.5%
0.07%
-2.6%
Q1 2015$1,915,000500,0000.08%
Other shareholders
IMMUNOMEDICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Avoro Capital Advisors LLC 10,488,076$92,610,00011.69%
First Light Asset Management, LLC 2,048,643$18,090,0006.07%
Foresite Capital Management III, LLC 1,940,850$17,138,0005.60%
DAFNA Capital Management LLC 637,700$5,631,0004.02%
ACUTA CAPITAL PARTNERS, LLC 1,600,000$14,128,0003.95%
Opaleye Management Inc. 900,000$7,947,0003.32%
Ghost Tree Capital, LLC 1,200,000$10,596,0002.20%
Iguana Healthcare Management, LLC 325,000$2,870,0001.62%
Healthcare Value Capital, LLC 100,000$883,0001.59%
Palo Alto Investors LP 3,010,466$26,582,0001.24%
View complete list of IMMUNOMEDICS INC shareholders